DES Product Iterations Previewed: Thinner Struts, “Stent-On-A-Wire”
This article was originally published in The Gray Sheet
Executive Summary
U.S. introduction of Johnson & Johnson/Cordis' Cypher Select next-generation sirolimus-eluting stent, initially planned for early 2004, could be delayed by a year if FDA requires six-month follow-up data to support approval of the new stent design